BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24244666)

  • 1. Targeting myeloid cells to the brain using non-myeloablative conditioning.
    Böttcher C; Fernández-Klett F; Gladow N; Rolfes S; Priller J
    PLoS One; 2013; 8(11):e80260. PubMed ID: 24244666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours.
    Youshani AS; Rowlston S; O'Leary C; Forte G; Parker H; Liao A; Telfer B; Williams K; Kamaly-Asl ID; Bigger BW
    J Neuroinflammation; 2019 Feb; 16(1):25. PubMed ID: 30722781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Busulfan as a myelosuppressive agent for generating stable high-level bone marrow chimerism in mice.
    Peake K; Manning J; Lewis CA; Barr C; Rossi F; Krieger C
    J Vis Exp; 2015 Apr; (98):e52553. PubMed ID: 25867947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow cell recruitment to the brain in the absence of irradiation or parabiosis bias.
    Kierdorf K; Katzmarski N; Haas CA; Prinz M
    PLoS One; 2013; 8(3):e58544. PubMed ID: 23526995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of myeloablation, peripheral chimerism, and whole-body irradiation on the entry of bone marrow-derived cells into the brain.
    Lampron A; Lessard M; Rivest S
    Cell Transplant; 2012; 21(6):1149-59. PubMed ID: 21944997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
    Down JD; Ploemacher RE
    Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Marrow-Derived Cell Accumulation in the Spinal Cord Is Independent of Peripheral Mobilization in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Peake K; Manning J; Lewis CA; Tran K; Rossi F; Krieger C
    Front Neurol; 2017; 8():75. PubMed ID: 28337172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation.
    Wilkinson FL; Sergijenko A; Langford-Smith KJ; Malinowska M; Wynn RF; Bigger BW
    Mol Ther; 2013 Apr; 21(4):868-76. PubMed ID: 23423338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoid reconstitution after transplantation of congenic hematopoietic cells in busulfan-treated mice.
    Yeager AM; Shinn C; Pardoll DM
    Blood; 1991 Dec; 78(12):3312-6. PubMed ID: 1683798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation.
    Ashizuka S; Peranteau WH; Hayashi S; Flake AW
    Exp Hematol; 2006 Mar; 34(3):359-68. PubMed ID: 16543070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelosuppressive conditioning using busulfan enables bone marrow cell accumulation in the spinal cord of a mouse model of amyotrophic lateral sclerosis.
    Lewis CA; Manning J; Barr C; Peake K; Humphries RK; Rossi F; Krieger C
    PLoS One; 2013; 8(4):e60661. PubMed ID: 23593276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.
    Ishida H; Kato M; Kudo K; Taga T; Tomizawa D; Miyamura T; Goto H; Inagaki J; Koh K; Terui K; Ogawa A; Kawano Y; Inoue M; Sawada A; Kato K; Atsuta Y; Yamashita T; Adachi S
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2141-2147. PubMed ID: 26271192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts.
    Lapidot T; Terenzi A; Singer TS; Salomon O; Reisner Y
    Blood; 1989 May; 73(7):2025-32. PubMed ID: 2653469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Homing characteristics of graft cells in leukemia mice after allogenic bone marrow transplantation with different conditioning regimens].
    Chen CP; Chen ZZ; Huang HF; Cai XY; He HX; Wu ZC; Luo XF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):137-41. PubMed ID: 22391184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Submyeloablative conditioning with busulfan permits bone marrow-derived cell accumulation in a murine model of Alzheimer's disease.
    Barr CM; Manning J; Lewis CA; Rossi FM; Krieger C
    Neurosci Lett; 2015 Feb; 588():196-201. PubMed ID: 25582787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic cell transplantation in the twitcher mouse. The effects of pretransplant conditioning with graded doses of busulfan.
    Yeager AM; Shinn C; Shinohara M; Pardoll DM
    Transplantation; 1993 Jul; 56(1):185-90. PubMed ID: 8101401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
    Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
    Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide in hematopoietic stem cell transplantation for malignant infantile osteopetrosis.
    Behfar M; Dehghani SS; Hosseini AS; Jalali A; Hamidieh AA; Ghavamzadeh A
    Pediatr Transplant; 2015 Jun; 19(4):422-7. PubMed ID: 25879376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning.
    Luo B; Nanji SA; Schur CD; Pawlick RL; Anderson CC; Shapiro AM
    Transplantation; 2005 Aug; 80(3):370-7. PubMed ID: 16082333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.